Kamada Ltd. (KMDA)
8.42
+0.18
(+2.18%)
USD |
NASDAQ |
Aug 24, 16:00
8.42
0.00 (0.00%)
After-Hours: 20:00
Kamada Enterprise Value : 417.07M for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 417.07M |
| August 20, 2026 | 404.38M |
| August 19, 2026 | 396.88M |
| August 18, 2026 | 396.88M |
| August 17, 2026 | 389.38M |
| August 14, 2026 | 378.99M |
| August 13, 2026 | 360.53M |
| August 12, 2026 | 338.60M |
| August 11, 2026 | 350.72M |
| August 10, 2026 | 353.61M |
| August 07, 2026 | 361.11M |
| August 06, 2026 | 353.61M |
| August 05, 2026 | 355.91M |
| August 04, 2026 | 365.14M |
| August 03, 2026 | 358.80M |
| July 31, 2026 | 353.61M |
| July 30, 2026 | 351.30M |
| July 29, 2026 | 346.10M |
| July 28, 2026 | 348.99M |
| July 27, 2026 | 344.95M |
| July 24, 2026 | 348.99M |
| July 23, 2026 | 343.22M |
| July 22, 2026 | 346.10M |
| July 21, 2026 | 361.68M |
| July 20, 2026 | 350.72M |
| Date | Value |
|---|---|
| July 17, 2026 | 348.41M |
| July 16, 2026 | 340.34M |
| July 15, 2026 | 354.18M |
| July 14, 2026 | 361.11M |
| July 13, 2026 | 355.34M |
| July 10, 2026 | 352.45M |
| July 09, 2026 | 354.18M |
| July 08, 2026 | 361.68M |
| July 07, 2026 | 363.41M |
| July 06, 2026 | 373.80M |
| July 02, 2026 | 374.38M |
| July 01, 2026 | 375.53M |
| June 30, 2026 | 365.14M |
| June 29, 2026 | 363.06M |
| June 26, 2026 | 357.30M |
| June 25, 2026 | 352.68M |
| June 24, 2026 | 350.08M |
| June 23, 2026 | 349.80M |
| June 22, 2026 | 353.26M |
| June 18, 2026 | 360.18M |
| June 17, 2026 | 357.30M |
| June 16, 2026 | 368.83M |
| June 15, 2026 | 368.83M |
| June 12, 2026 | 367.68M |
| June 11, 2026 | 367.68M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| BioLineRx Ltd. | 8.106M |
| XTL Biopharmaceuticals Ltd. | -- |
| Can-Fite BioPharma Ltd. | -4.518M |
| Galmed Pharmaceuticals Ltd. | -12.02M |
| Revium Recovery, Inc. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 9.262M |
| Revenue (Quarterly) | 54.92M |
| Total Expenses (Quarterly) | 45.66M |
| EPS Diluted (Quarterly) | 0.1605 |
| Gross Profit Margin (Quarterly) | 40.91% |
| Profit Margin (Quarterly) | 16.86% |
| Earnings Yield | 4.53% |
| Operating Earnings Yield | 5.63% |
| Normalized Earnings Yield | 4.651 |